ibandronic acid 150 MG (as ibandronate sodium 168.75 MG) Oral Tablet
- RxCUI
- 904932
- RxNorm name
- ibandronic acid 150 MG (as ibandronate sodium 168.75 MG) Oral Tablet
- Display name
- ibandronic acid 150 MG (as ibandronate sodium 168.75 MG) Oral Tablet
- Full name
- ibandronic acid 150 MG (as ibandronate sodium 168.75 MG) Oral Tablet
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:29
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ibandronate Sodium | IBANDRONATE SODIUM | Aurobindo Pharma Limited | 86c0b4ae-5e38-4efe-88af-50ac560e294f | 2026-03-18 | Warnings, Adverse reactions | 904932 |
| IBANDRONATE SODIUM | IBANDRONATE SODIUM | Golden State Medical Supply, Inc. | 618e1aff-ccbb-4cee-93f1-fe04e33dacb7 | 2026-02-19 | Warnings, Adverse reactions | 904932 |
| Ibandronate sodium | IBANDRONATE SODIUM | Dr. Reddy's Laboratories Limited | f94d9c49-245a-8081-42c4-785113fce498 | 2026-02-16 | Warnings, Adverse reactions | 904932 |
| IBANDRONATE SODIUM | IBANDRONATE SODIUM | Macleods Pharmaceuticals Limited | a5741ef6-0599-4657-8cda-2902ded4f680 | 2026-01-19 | Warnings, Adverse reactions | 904932 |
| Ibandronate sodium | IBANDRONATE SODIUM | A-S Medication Solutions | e5b6c2a9-a55f-41f9-a592-e26ef03e2d73 | 2025-09-22 | Warnings, Adverse reactions | 904932 |
| IBANDRONATE SODIUM | IBANDRONATE SODIUM | Bionpharma Inc. | 6ca94cce-a2bb-421f-bd8f-6b14bc2bd985 | 2023-05-23 | Warnings, Adverse reactions | 904932 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f94d9c49-245a-8081-42c4-785113fce498 | ibandronate sodium 150 MG Oral Tablet [PSN] · ibandronic acid 150 MG Oral Tablet [SCD] · ibandronic acid 150 MG (as ibandronate sodium 168.75 MG) Oral Tablet [SY] | 3 | 22 | These highlights do not include all the information needed to use IBANDRONATE SODIUM TABLETS safely and effectively. See full prescribing information for IBANDRONATE SODIUM TABLETS. IBANDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 2003 | 20251027 |
| dd674424-b151-d7eb-3acf-b1589347f2f7 | ibandronate sodium 150 MG Oral Tablet [PSN] · ibandronic acid 150 MG Oral Tablet [SCD] · ibandronic acid 150 MG (as ibandronate sodium 168.75 MG) Oral Tablet [SY] | 3 | 20 | These highlights do not include all the information needed to use IBANDRONATE SODIUM TABLETS safely and effectively. See full prescribing information for IBANDRONATE SODIUM TABLETS. IBANDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 2003 | 20260115 |
| 86c0b4ae-5e38-4efe-88af-50ac560e294f | ibandronate sodium 150 MG Oral Tablet [PSN] · ibandronic acid 150 MG Oral Tablet [SCD] · ibandronic acid 150 MG (as ibandronate sodium 168.75 MG) Oral Tablet [SY] | 3 | 12 | These highlights do not include all the information needed to use IBANDRONATE SODIUM TABLETS safely and effectively. See full prescribing information for IBANDRONATE SODIUM TABLETS. IBANDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 2003 | 20260318 |
| 618e1aff-ccbb-4cee-93f1-fe04e33dacb7 | ibandronate sodium 150 MG Oral Tablet [PSN] · ibandronic acid 150 MG Oral Tablet [SCD] · ibandronic acid 150 MG (as ibandronate sodium 168.75 MG) Oral Tablet [SY] | 3 | 12 | IBANDRONATE SODIUM TABLETS. These highlights do not include all the information needed to use IBANDRONATE SODIUM TABLETS safely and effectively. See full prescribing information for IBANDRONATE SODIUM TABLETS. IBANDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 2003 | 20260219 |
| a5741ef6-0599-4657-8cda-2902ded4f680 | ibandronate sodium 150 MG Oral Tablet [PSN] · ibandronic acid 150 MG Oral Tablet [SCD] · ibandronic acid 150 MG (as ibandronate sodium 168.75 MG) Oral Tablet [SY] | 3 | 12 | These highlights do not include all the information needed to use IBANDRONATE SODIUM TABLETS safely and effectively. See full prescribing information for IBANDRONATE SODIUM TABLETS. IBANDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 2003 | 20260119 |
| 6ca94cce-a2bb-421f-bd8f-6b14bc2bd985 | ibandronate sodium 150 MG Oral Tablet [PSN] · ibandronic acid 150 MG Oral Tablet [SCD] · ibandronic acid 150 MG (as ibandronate sodium 168.75 MG) Oral Tablet [SY] | 3 | 2 | These highlights do not include all the information needed to use IBANDRONATE SODIUM TABLETS safely and effectively. See full prescribing information for IBANDRONATE SODIUM TABLETS. IBANDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 2003 | 20230523 |
| e5b6c2a9-a55f-41f9-a592-e26ef03e2d73 | ibandronate sodium 150 MG Oral Tablet [PSN] · ibandronic acid 150 MG Oral Tablet [SCD] · ibandronic acid 150 MG (as ibandronate sodium 168.75 MG) Oral Tablet [SY] | 3 | 1 | These highlights do not include all the information needed to use IBANDRONATE SODIUM TABLETS safely and effectively. See full prescribing information for IBANDRONATE SODIUM TABLETS. IBANDRONATE SODIUM tablets, for oral use Initial U.S. Approval: 2003 | 20250922 |
| d6d7711f-541b-47d1-b937-2c6a021eb6c3 | ibandronate sodium 150 MG Oral Tablet [PSN] · ibandronic acid 150 MG Oral Tablet [SCD] · ibandronic acid 150 MG (as ibandronate sodium 168.75 MG) Oral Tablet [SY] | 3 | 1 | These highlights do not include all the information needed to use BONIVA Tablets safely and effectively. See full prescribing information for BONIVA Tablets. BONIVA® (ibandronate sodium) Tablets Initial U.S. Approval: 2003 | 20101202 |